Registrieren Sie sich kostenlos
für unseren Newsletter!
für unseren Newsletter!
Loading...
Artikelnummer:
5600132
CAS Nr.:
863971-19-1
Formel:
C49J76N6O11
Molekulargewicht:
925,16 g/mol
McMMAF is a protective group-conjugated MMAF. MMAF is a potent tubulin polymerization inhibitor. MMAF is a new auristatin derivative with a charged C-terminal phenylalanine that attenuates its cytotoxic activity compared to its uncharged counterpart, Monomethyl auristatin E (MMAE). Because of MMAF is highly toxic, it cannot be used as a drug itself. MMAF induces potent antitumor effects when conjugated via protease cleavable linkers to a monoclonal antibody targeting internalizing, tumor-specific cell surface antigens. The linker to the monoclonal antibody is stable in extracellular fluid, but is cleaved by cathepsin once the conjugate has entered a tumor cell, thus activating the anti-mitotic mechanism. Potential mode of action/Key words: Targeting Tubulin, Tubulin polymerization inhibitor, Cytotoxic
Cfm Oskar Tropitzsch GmbH bietet auch Linker-Drug-Konjugate an. Entweder als verfügbares Linker-Drug Konjugat oder mittels Auftragssynthese speziell auf Ihre Wünsche zugeschnitten. Nehmen Sie für weitere Details Kontakt zu uns auf